Alpharma News
Most Popular Alpharma Story
FDA: Embeda could carry abuse risk
FDA staffers have expressed concern that Alpharma's powerful painkiller Embeda could be abused even though the company designed the drug not to be. Embeda contains morphine sulfate and Duramorph. Read more...
Latest Headlines
- November 24, 2008
- November 13, 2008
- October 13, 2008
- September 26, 2008
- September 26, 2008
- September 12, 2008
- September 11, 2008
- September 10, 2008
- August 22, 2008
- April 29, 2008
- April 22, 2008
- November 30, 2007
- September 13, 2007
- September 6, 2007
- August 21, 2007
- December 5, 2006
- September 5, 2006
- October 26, 2005
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
